ArisGlobal, a cutting-edge technology company leading in life sciences and creator of LifeSphere®, and Sitero LLC, a provider of advanced clinical trial solutions, have announced a growth in their strategic partnership. The merging incorporates Sitero's comprehensive eClinical technology platform - comprising Mentor EDC/ePRO, RTSM, eConsent, Payments and CTMS/eTMF - into ArisGlobal's LifeSphere R&D technology suite.

This enhanced collaboration provides unmatched solutions to global life sciences clients of ArisGlobal & Sitero. The integrated approach enables a smooth experience throughout the whole R&D IT system. This unified platform gets rid of the necessity for entering data twice and reconciling data; uses smart intake of important case data; and simplifies the entire process of data and document processing in research and development. The improved data harmonization outcome results in higher trial accuracy, efficiency, and subject safety.

"ArisGlobal's strategic initiatives and investments are prioritized based on end-user benefits and process optimization to deliver true value and return on investment (ROI) for our Global partners," shared Aman Wasan, CEO at ArisGlobal. "LifeSphere has invested in powerful platforms in Safety, Regulatory, Medical Affairs and Quality, powered by LifeSphere NavaX, our next-generation cognitive computing engine that delivers enhanced value with advanced Gen AI and LLM solutions. Sitero has developed an equally formidable eClinical platform that includes advanced clinical and data management capabilities. Our integration enables us to jointly offer the most innovative and comprehensive life sciences R&D technology platform," Wasan added.